Meiji Holdings Co., Ltd.
2269.T · JPX
Company research
Meiji Holdings Co., Ltd. (TSE: 2269) is a Tokyo-based Japanese holding company established in April 2009 through the merger of Meiji Dairies Corporation, Japan's largest dairy company, and Meiji Seika Kaisha, the country's second-largest confectionery maker, with roots tracing back to 1916. The company operates through two core business segments — Food and Pharmaceuticals — with the Food segment accounting for approximately 80% of group sales, encompassing dairy products (milk, yogurt, cheese, ice cream), confectioneries (chocolate, gummy candies), nutritional products (infant formula, sports nutrition, beauty supplements), and frozen foods. The Pharmaceutical segment, operated through its subsidiary Meiji Seika Pharma, focuses on ethical pharmaceuticals targeting infectious diseases and central nervous system disorders, alongside generic drugs, vaccines, blood plasma products, and veterinary medicines for livestock and companion animals. With a market capitalization of approximately ¥1 trillion JPY and a global presence spanning Japan, China, Asia, North America, and Europe, Meiji Holdings is recognized as one of the world's largest confectionery producers and a leading player in Japan's packaged foods and pharmaceutical industries.
Research reports
HDIN Research describes Meiji’s capital‑intensive “J‑curve” transformation, highlighting a $693.3 million FY2025 fixed‑asset capex program, unwinding $534.9 million in cross‑shareholdings and an 8.0% FY2026 ROE target funded by operating cash flow, new debt and cash reserves, while emphasizing vaccine‑led pharmaceutical growth and premiumization in the food segment to defend margins and shareholder returns.
Yahoo Finance / Simply Wall St · November 24, 2025Meiji Holdings (TSE:2269): Gauging Valuation After Earnings Guidance Update and Higher Interim DividendThis syndicated analysis reviews Meiji’s updated consolidated earnings guidance and higher interim dividend, comparing a commonly accepted fair value of around ¥3,328.57 to a share price near ¥3,180 and noting a small apparent undervaluation, but also highlighting Meiji’s above‑peer price‑to‑earnings ratio and mixed valuation signals that leave the overall outlook nuanced rather than clearly positive or negative.
Simply Wall St / Webull · October 9, 2025Meiji Holdings Co., Ltd.'s (TSE:2269) Intrinsic Value Is Potentially 79...This Simply Wall St–syndicated note uses a two‑stage DCF with a 4.7% cost of equity and levered beta of 0.8, estimating equity value of roughly ¥1.4 trillion and concluding that Meiji shares trade at about a 44% discount to intrinsic value, while acknowledging that the valuation is sensitive to cash‑flow and discount‑rate assumptions and does not capture all qualitative or cyclical risks.